Compositions and methods for the diagnosis of lyme disease
US11061028B2 · kind B2 · utility
0Cited by
16References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 23, 2015 |
| Grant date | Jul 13, 2021 |
| Priority date | — |
| Expiry date | Dec 31, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
This disclosure provides antigen compositions useful for diagnosing Lyme disease and for detecting antibodies that bind to Borrelia antigens. The antigenic compositions comprise a mixture of hybrid peptides and Borrelia proteins. This disclosure also provides devices, methods, and kits that are useful for diagnosing Lyme disease and for detecting anti-Borrelia antibodies in a sample to aid in the diagnosis of Lyme disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.